2018Chinese Journal of AsthmaRequires access

Research progress of anxiety and depression in patients with chronic obstructive pulmonary disease

Kewen Jian, Qiuhua Zhang, Yirou Chen, Chunyan Chen

Open publisher page 0 citations

Abstract

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD), which occur more frequently in persons with COPD than in persons without COPD.Co-morbid anxiety and depression are associated with the interaction of multiple factors, including behavioral, social and biological factors.Although anxiety and depression exert a considerably negative impact on the course and prognosis of COPD, the identification and management of co-morbid anxiety and depression is inadequate in the clinical setting.There is some evidence for the efficacy of pulmonary rehabilitation, pharmacological treatments and psychological therapy in reducing anxiety and depression in patients with COPD, but there is no consensus as to the most appropriate managing approach. Key words: Chronic obstructive pulmonary disease; Anxiety; Depression; Comorbidities

About this research paper

What this paper is about

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD), which occur more frequently in persons with COPD than in persons without COPD.Co-morbid anxiety and depression are associated with the interaction of multiple factors, including behavioral, social and biological factors.Although anxiety and depression exert a considerably negative impact on the course and prognosis of COPD, the identification and management of co-morbid anxiety and depression is inadequate in the clinical setting.There is some evidence for the efficacy of pulmonary rehabilitation, pharmacological treatments and psychological therapy in reducing anxiety and depression in patients with COPD, but there is no consensus as to the most appropriate managing approach. Key words: Chronic obstructive pulmonary disease; Anxiety; Depression; Comorbidities

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD), which occur more frequently in persons with COPD than in persons without COPD.Co-morbid anxiety and depression are associated with the interaction of multiple factors, including behavioral, social and biological factors.Although anxiety and depression exert a considerably negative impact on the course and prognosis of COPD, the identification and management of co-morbid anxiety and depression is inadequate in the clinical setting.There is some evidence for the efficacy of pulmonary rehabilitation, pharmacological treatments and psychological therapy in reducing anxiety and depression in patients with COPD, but there is no consensus as to the most appropriate managing approach. Key words: Chronic obstructive pulmonary disease; Anxiety; Depression; Comorbidities

Key concepts: Medicine, COPD, Anxiety, Depression (economics), Pulmonary disease, Pulmonary rehabilitation, Disease, Rehabilitation

Related papers

Back to paper searchBrowse research topicsOriginal source
Research progress of anxiety and depression in patients with chronic obstructive pulmonary disease — Research Paper | ScholarLens